Q2 2025 Management View Thomas Sandgaard, Founder, President, CEO & Chairman, announced, "The second quarter of 2025 was ...

Zynex's turnaround is nearing an end as UnitedHealthcare's new policy cuts its payments by 80% - equivalent to 40-100% of 2021 EBITDA. We recommend initiating short positions.

If Zynex would publicize (even in a general sense) its billings practices and how it’s achieving its reimbursement levels, the transparency would benefit patients, insurers and investors.

Q2 2025 Earnings Call Transcript July 31, 2025 Zynex, Inc. misses on earnings expectations. Reported EPS is $-0.66 EPS, expectations were $-0.13. Operator: Good afternoon, ladies and gentlemen, and ...

Zynex (NASDAQ:ZYXI), a medical technology company specializing in non-opioid pain management devices, issued its second quarter 2025 results on July 31, 2025. The release highligh ...

Zynex Chief Financial Officer Dan Moorhead is resigning. Moorhead plans to leave Aug. 29 and the move isn't the result of a disagreement with the company, the medical device maker said Tuesday.

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient ...

Zynex, Inc. (NASDAQ:ZYXI) shareholders are no doubt pleased to see that the share price has bounced 29% in the last month, although it is still struggling to make up recently lost ground ...

On April 28, Zynex will release figures for the most recent quarter. Analysts expect Zynex will release earnings per share of $0.048. Follow Zynex stock price in real-time on Markets Insider here.

Indeed, Zynex expects to have 500 sales reps in the US by the end of 2020 and over 600 by the end of 2021 (up from 400 sales reps in early September).Shares in Zynex have exploded by over 90% year ...

Zynex secured the 23rd spot on the list, marking its second consecutive appearance in the top 100. Sandgaard says this is the second year in a row that Zynex has received recognition in The ...